05/06/2026 11:01
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). This agreement secures sustainable access to this innovative one-time treatment for eligible patients in Germany ages 12 years and older living with severe sickle cell disease or transfusion-dependent beta thalassemia. “For the first time in Germany, a long-term, sustainable access...

05/06/2026 11:00
NIQ Launches AI-Powered Platform to Help Brands Test Pricing Decisions Before They Go to Market

As manufacturers face mounting pressure to protect margins, justify trade spend, and respond faster to shifting consumer demand, NIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the commercial launch of Price & Promo Optimizer, a next‑generation, AI‑enabled Revenue Growth Management (RGM) platform built to fundamentally change how pricing and promotion decisions are made. Today, many pricing and promotion decisions are still made across disconnected tools, manual...

05/06/2026 11:30
Elisa Expands PON Deployment with Vecima’s All-PON™ Shelf, Delivering 10G Fiber Services in Estonia

Vecima Networks Inc. (TSX: VCM) announced today that leading telecommunications operator Elisa has deployed Vecima’s Entra EXS1610 All-PON™ Shelf for 10G Fiber-to-the-Home (FTTH) services for its subscribers in Estonia. In Estonia’s competitive broadband market, Elisa brings highly innovative solutions to its subscribers. Vecima’s EXS1610 supports multiple deployment use cases, including greenfield, targeted brownfields, rural edge-outs, hybrid fiber-coax (HFC) overbuilds, footprint extension...

05/06/2026 12:00
Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program

Waiv, formerly Owkin Dx, a Paris-based company catalyzing AI precision testing, today announced it has entered a collaboration with Daiichi Sankyo (TSE: 4568) to lead digital pathology biomarker discovery for an antibody-drug conjugate (ADC) program. With deep expertise across diverse pathology and multimodal data, and a global data network spanning academic institutions, hospitals, and laboratories, Waiv has a proven track record delivering AI-powered biomarker solutions across the full drug...

Conditions générales applicables au paiement par carte bancaire / Europe

Conditions générales applicables au paiement par carte bancaire / Europe

General terms and conditions applicable to payment by credit card / Europe

Last update: 2024

 

These general terms and conditions (the "GTC") govern the contractual conditions applicable to the online payment of your invoices by credit card, without prejudice to the provisions of the content license agreement entered into between you and AFP.

By accepting these GTC online at the time of payment by credit card, you agree to abide by them.

For the purposes of these GTC, the terms :

 

05/06/2026 12:00
Vultr, SUSE & Supermicro Debut Unified Cloud-to-Edge Architecture for Global AI Scaling

Vultr, the world's largest privately-held cloud infrastructure company, in collaboration with SUSE and Supermicro, today announces a strategic architectural framework designed to solve the complexities of deploying and operating AI workloads across distributed environments. As AI moves closer to the point of data creation - from manufacturing floors to retail storefronts - organizations face significant challenges in latency, cost and operational consistency. This joint initiative provides a ...

05/06/2026 12:00
XBOW Secures Additional $35M from Strategic Investors, Including Select Customers and Ecosystem Partners

XBOW, the leader in autonomous offensive security, today announced $35 million in additional Series C financing from investors Accenture Ventures, DNX Ventures, Liberty Global Tech Ventures, NVentures (NVIDIA’s venture capital arm), Samsung Ventures, and SentinelOne S Ventures. The raise extends its previously announced $120 million Series C round, and highlights a broader shift: major enterprises are not just adopting XBOW’s platform, but investing in it as they look to keep pace with increasi...